Dyslipidemia Is Related to Mortality in Critical Patients With Coronavirus Disease 2019: A Retrospective Study

Jiang Yue1, Hua Xu1, Yong Zhou2

  • 1Department of Endocrinology and Metabolism, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Insights

Lipid metabolic disorders are present in critical COVID-19 patients. Lower high-density lipoprotein cholesterol (HDL-c) and total cholesterol (TC) levels are linked to disease progression and mortality in these patients.

Area of Science:

  • Biochemistry
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Dyslipidemia has been linked to coronavirus-related diseases.
  • Critical coronavirus disease 2019 (COVID-19) patients with multiple organ dysfunctions were admitted to the ICU.
  • The association between lipid profiles and prognosis in critical COVID-19 patients was unclear.

Purpose of the Study:

  • To investigate the association between lipid profiles and prognosis in critical COVID-19 patients.
  • To identify potential lipid biomarkers for COVID-19 severity.

Main Methods:

  • A retrospective study of 48 critical COVID-19 patients in Wuhan.
  • Collected lipid profiles, liver function, and renal function parameters on admission, at 2-3 days post-admission, and before clinical outcome.
  • Utilized logistic regression to analyze associations with mortality.

Main Results:

  • Albumin and creatine kinase levels decreased significantly post-admission.
  • Low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), apolipoprotein A (ApoA), and apolipoprotein B (ApoB) levels decreased after admission.
  • Lower HDL-c levels on admission and before outcome were negatively associated with mortality.
  • Total cholesterol (TC) levels at 2-3 days post-admission were related to mortality.

Conclusions:

  • Critical COVID-19 patients exhibit lipid metabolic disorders.
  • Lower HDL-c and TC levels correlate with disease progression and mortality in critical COVID-19.
  • Lipid profiles may serve as prognostic indicators for critical COVID-19 patients.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
428
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
371
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
553
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.0K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
84
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.3K